M&A Deal Summary |
|
|---|---|
| Date | 2025-05-29 |
| Target | Nordson - Design and Development Business |
| Sector | Medical Products |
| Buyer(s) | Quasar |
| Sellers(s) | Nordson |
| Deal Type | Divestiture |
SEARCH BY
Quasar is a contract development and manufacturing organization (“CDMO”) for bluechip medical device companies globally and an industry leader in the development and manufacturing of complex minimally invasive cardiovascular diagnostics and therapeutic catheters as well as other high-precision medical products and healthcare-related devices. Quasar was established in 1988 and is based in Hong Kong, China.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
Nordson delivers precision technology solutions to help customers succeed worldwide. The company engineers, manufactures and markets differentiated products and systems used for dispensing adhesives, coatings, sealants, biomaterials and other materials, fluid management, test and inspection, UV curing and plasma surface treatment, all supported by application expertise and direct global sales and service. Nordson was founded in 1935 and is based in Westlake, Ohio.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-05-28 |
Atrion
Allen, Texas, United States Atrion provides proprietary medical infusion fluid delivery and niche cardiovascular solutions. The company supports customers globally through three specialized FDA-registered manufacturing facilities located in the United States. Atrion was formed in 1944 and is based in Allen, Texas. |
Buy | $815M |
